An angiogenic role for the human peptide antibiotic LL-37/hCAP-18

Journal of Clinical Investigation

Volumn 111, Issue 11, 2003, Pages 1665-1672

  Koczulla, Rembert ^a,b   Von Degenfeld, Georges ^b   Kupatt, Christian ^b   Krötz, Florian ^c   Zahler, Stefan ^c   Gloe, Torsten ^c   Issbrücker, Katja ^d   Unterberger, Pia ^c   Zaiou, Mohamed ^e,g   Lebherz, Corinna ^b   Karl, Alexander ^c   Raake, Philip ^b   Pfosser, Achim ^b   Boekstegers, Peter ^b   Welsch, Ulrich ^c   Hiemstra, Pieter S ^f   Vogelmeier, Claus ^a   Gallo, Richard L ^e,g   Clauss, Matthias ^d   Bals, Robert ^a,b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; PEPTIDE ANTIBIOTIC LL 37; PEPTIDE HCAP 18; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN CRAMP; UNCLASSIFIED DRUG; ACETYLCYSTEINE; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BISINDOLYLMALEIMIDE I; CALCIUM; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; CELL SURFACE RECEPTOR; COLLAGEN; ENZYME INHIBITOR; FORMYLPEPTIDE RECEPTOR; FPRL1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLE DERIVATIVE; LAMININ; LIPOXIN RECEPTOR; MALEIMIDE DERIVATIVE; MATRIGEL; PEPTIDE; PRODRUG; PROTEOGLYCAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; LEUKOCYTE; LIMB ISCHEMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RABBIT; WOUND HEALING; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; GENETICS; HAMSTER; ISCHEMIA; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYRIAN HAMSTER; TIME; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ACETYLCYSTEINE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CELL DIVISION; CELLS, CULTURED; COLLAGEN; CRICETINAE; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; INDOLES; INFLAMMATION; ISCHEMIA; LAMININ; MALEIMIDES; MESOCRICETUS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; PEPTIDES; PRODRUGS; PROTEOGLYCANS; RABBITS; RECEPTORS, CELL SURFACE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; WOUND HEALING;

EID: 0038142308     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17545     Document Type: Article

References (37)

1. Ganz, T. 1999. Defensins and host defense. Science. 286:420-421.
2. Bals, R. 2000. Epithelial antimicrobial peptides in host defense against infection. Respir. Res. 1:141-150.
3. Zanetti, M., Gennaro, R., and Romeo, D. 1995. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374:1-5.
4. Bals, R., Wang, X., Zasloff, M., and Wilson, J.M. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U. S. A. 95:9541-9546.
5. Agerberth, B., et al. 2000. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 96:3086-3093.
6. Gudmundsson, G.H., et al. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biocbem. 238:325-332.
7. Cowland, J., Johnsen, A., and Borregaard, N. 1995. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368:173-176.
8. Frohm, M., et al. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258-15263.
9. Frohm, M., et al. 1996. Biochemical and antibacterial analysis of human wound and blister fluid. Eur. J. Biochem. 237:86-92.
10. Sorensen, O., Cowland, J., Askaa J., and Borregaard, N. 1997. An ELISA for hCAP-18, the cathelicidine present in human neutrophils and plasma. FEBS Lett. 206:53-59.
11. Agerberth, B., et al. 1999. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 160:283-290.
12. Nizet, V., et al. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 414:454-457.
13. Ong, P.Y., et al. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151-1160.
14. Yang, C., et al. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T-cells. J. Exp. Med. 192:1069-1074.
15. Buschmann, I., and Schaper, W. 2000. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190:338-342.
16. Carmeliet, P. 2000. Mechanisms of angiogenesis. Nat. Med. 6:389-395.
17. Zahler, S., Kupatt, C., and Becker, B.F. 2000. Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-alpha. FASEB J. 14:555-564.
18. Garcia, J.R., et al. 2001. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306:257-264.
19. Aarbiou, J., et al. 2002. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J. Leukoc. Biol. 72:167-174.
20. Zaiou, M., Nizet, V., and Gallo, R.L. 2003. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP-18/LL-37) prosequence. J. Invest. Dermatol. 120:880-890.
21. Fiore, S., and Serhan, C.N. 1995. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry. 34:16678-16686.
22. Dorschner, R.A., et al. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117:91-97.
23. Drexler, H.C., Risau, W., and Konerding, M.A. 2000. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J. 14:65-77.
24. Issbrucker, K., et al. 2003. p38 MAP kinase - a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J. 17:262-264.
25. Takeshita, S., et al. 1994 Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93:662-670.
26. Murohara, T., et al. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101:2567-2578.
27. Gibson, C.M., et al. 1996. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 93:879-888.
28. Bals, R., et al. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102:874-880.
29. Ribatti, D., et al. 1997. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J. Vasc. Res. 34:455-463.
30. Wang, Y., Agerberth, B., Lothgren, A, Almstedt, A., and Johansson, J. 1998. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J. Biol. Chem. 273:33115-33118.
31. Li, B.Q., et al. 2001. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1. Blood. 97:2941-2947.
32. Hu, J.Y., et al. 2001. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leuloc. Biol. 70:105-161.
33. Baek, S.H., et al. 1999. Trp-Lys-Tyr-Met-Val-Met activates mitogen-activated protein kinase via a PI-3 kinase-mediated pathway independent of PKC. Life Sci. 65:1845-1856.
34. Zarember, K.A., et al. 2002. Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes. Infect. Immun. 70:569-576.
35. Li, J., et al. 2000. PR39, a peptide regulator of angiogenesis. Nat. Med. 6:49-55.
36. Sorensen, O.E., et al. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 97:3951-3959.
37. Bals, R., Weiner, D.J., Meegalla, R.L., Accurso, F., and Wilson, J.M. 2001. Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid. Am. J. Respir. Cell. Mol. Biol. 25:21-25.